{"id":"W2140051179","doi":"10.1191/1352458505ms1205oa","title":"Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society","keywords":"Natalizumab; Multiple sclerosis; Medicine; Internal medicine; Placebo; Lesion; Gastroenterology; Clinical trial; Phases of clinical research; Surgery; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006099504,0.0008453006,0.001447658,0.0003109649,0.0004218479,0.0007568038,0.0005119938,0.001033084,0.001217437],"category_scores_gemma":[0.005423228,0.0004813158,0.001119815,0.0002541007,0.0005697439,0.0005350803,0.0003977959,0.00196552,0.0002727461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004799754,"about_ca_system_score_gemma":0.0008545308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002659659,"about_ca_topic_score_gemma":0.0003513729,"domain_scores_codex":[0.9968906,0.002136514,0.0002194947,0.0002697013,0.0002650489,0.0002187451],"domain_scores_gemma":[0.9961435,0.001411368,0.00115885,0.0003505959,0.0001732637,0.0007623625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8409691,0.02341284,0.07874254,0.0003275402,0.002006432,0.0002206037,0.0004082314,0.001048093,0.0153028,0.0001202124,0.001054312,0.03638729],"study_design_scores_gemma":[0.2600408,0.4669838,0.2601328,0.00006630344,0.001728371,0.0006935595,0.0001304516,0.003369235,0.004830112,0.0002677728,0.001686542,0.00007005805],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986101,0.000529026,0.0001166575,0.00007423347,0.00002305779,0.0003113853,0.00009799415,0.000008949532,0.0002285743],"genre_scores_gemma":[0.9979526,0.0001892358,0.0002988385,0.000191825,0.00005473749,0.0006525521,0.0003736346,0.000005795643,0.0002807301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006099504,"threshold_uncertainty_score":0.03225768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1414482400217475,"score_gpt":0.348538242617605,"score_spread":0.2070900025958576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}